1. Home
  2. PTCT vs ABG Comparison

PTCT vs ABG Comparison

Compare PTCT & ABG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • ABG
  • Stock Information
  • Founded
  • PTCT 1998
  • ABG 1996
  • Country
  • PTCT United States
  • ABG United States
  • Employees
  • PTCT N/A
  • ABG N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • ABG Retail-Auto Dealers and Gas Stations
  • Sector
  • PTCT Health Care
  • ABG Consumer Discretionary
  • Exchange
  • PTCT Nasdaq
  • ABG Nasdaq
  • Market Cap
  • PTCT 4.1B
  • ABG 4.4B
  • IPO Year
  • PTCT 2013
  • ABG N/A
  • Fundamental
  • Price
  • PTCT $61.09
  • ABG $244.26
  • Analyst Decision
  • PTCT Buy
  • ABG Hold
  • Analyst Count
  • PTCT 14
  • ABG 7
  • Target Price
  • PTCT $67.00
  • ABG $259.67
  • AVG Volume (30 Days)
  • PTCT 1.4M
  • ABG 137.7K
  • Earning Date
  • PTCT 11-06-2025
  • ABG 10-28-2025
  • Dividend Yield
  • PTCT N/A
  • ABG N/A
  • EPS Growth
  • PTCT N/A
  • ABG 39.67
  • EPS
  • PTCT 7.72
  • ABG 27.38
  • Revenue
  • PTCT $1,764,929,000.00
  • ABG $17,262,800,000.00
  • Revenue This Year
  • PTCT $119.89
  • ABG $7.62
  • Revenue Next Year
  • PTCT N/A
  • ABG $8.94
  • P/E Ratio
  • PTCT $7.91
  • ABG $8.92
  • Revenue Growth
  • PTCT 96.00
  • ABG 8.40
  • 52 Week Low
  • PTCT $31.80
  • ABG $201.68
  • 52 Week High
  • PTCT $62.18
  • ABG $312.56
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 75.37
  • ABG 46.99
  • Support Level
  • PTCT $57.47
  • ABG $246.45
  • Resistance Level
  • PTCT $58.73
  • ABG $253.63
  • Average True Range (ATR)
  • PTCT 2.04
  • ABG 6.58
  • MACD
  • PTCT 0.96
  • ABG -1.15
  • Stochastic Oscillator
  • PTCT 92.16
  • ABG 9.56

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About ABG Asbury Automotive Group Inc

Asbury Automotive Group is a regional collection of automobile dealerships that went public in March 2002. The company operates 152 new-vehicle stores and 37 collision centers. Over 70% of new-vehicle revenue is from luxury and import brands. Asbury also offers third-party financing and insurance products and its own F&I products via Total Care Auto. Asbury operates in 14 states (mostly Texas, the West, the Mid-Atlantic, and the Southeast). Asbury store brands include McDavid and Park Place in Texas, Koons in the Washington, D.C. area, and the Larry H. Miller brand in the Western US. Asbury generated $17.2 billion of revenue in 2024 and is based in the Atlanta area. The firm targets at least $30 billion of revenue sometime around 2030.

Share on Social Networks: